Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for Acute ICU Delirium
NCT00351299Phase 2Completed
- Sponsor
- Brigham and Women's Hospital
- Start
- Jan 2006
- Primary completion
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in delirium comparing Infusion of dexmedetomidine with Standard of Care (2 arms). Primary endpoint: Resolution of Delirium up to 7 days. Started Jan 2006; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
delirium
Beyond the preview
Go deeper on NCT00351299.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00351299.